Abstract Search

ea0081p515 | Late-Breaking | ECE2022

Parathormone washout in cytology of Suspicious for Follicular Neoplasm

Durmaz Himmet , Cavnar Helvacı Burcak , Beştepe Nagihan , Aksoy Altınboğa Ayşegul , Dirikoc Ahmet , Topaloglu Oya , Ersoy Reyhan , Cakir Bekir

Introduction: The risk of malignancy in thyroid nodules is reported by the Bethesda system by performing fine needle aspiration biopsy (FNAB). Atypia of undetermined significance(AUS) or follicular lesion of undetermined significance(FLUS)(Bethesda 3) and suspicious for a follicular neoplasm (Bethesda 4) create uncertainty about treatment and follow-up. Molecular tests, ultrasonographic features of the nodules, and calcitonin level help us for this uncertainty. Here, we will p...

0 shares

ea0073aep894 | Late Breaking | ECE2021

Radioactive iodine therapy with recombinant human TSH (rhTSH) for well-differentiated thyroid cancer had no difference in GO outcome; case report

Faki Sevgul , Deniz Serdar , Burçak Cavnar Helvacı , Çağlar Keskin , Burçak Polat , Nilay Yüksel , Şeyda Türkölmez , Oya Topaloğlu , Ersoy Reyhan , BekirÇakir

BackgroundThe risk of cancer is relatively higher in Graves patients presenting simultaneously with thyroid nodules. Radioiodine (RAI) therapy recommended in intermediate-high risk differentiated thyroid carcinoma may be associated with worsening of a pre-existing Graves orbitopathy (GO) or developing a new onset. The impact of RAI therapy in patients with differentiated thyroid cancer on the course of a pre-exisiting GO has not been specific...

0 shares

Endocrine Abstracts

Parathormone washout in cytology of Suspicious for Follicular Neoplasm

Radioactive iodine therapy with recombinant human TSH (rhTSH) for well-differentiated thyroid cancer had no difference in GO outcome; case report

BiosciAbstracts